IMAAVY TM (nipocalimab-aahu) is a first-in-class FcRn (neonatal Fc receptor) inhibitor, designed to reduce the levels of ...

The 25th anniversary celebration of the Wings Over Wall Street benefit will recognize ALS researchers and advocates.

A recent discovery of a molecular connection between autism and myotonic dystrophy, a type of neuromuscular disease, may provide a breakthrough on how clinicians approach autism spectrum disorder.

Dyne Therapeutics, Inc.’s DYN share price has surged by 5.54%, which has investors questioning if this is right time to sell.

For more than 75 years, MDA has led the fight against ALS, investing more than $178 million in ALS research to date and supporting families through a national network of 150 MDA Care Centers, ...

Frank battled a degenerative disease in 'The Last of Us,' but the show never specified the name of his illness ...

New research has uncovered a genetic connection between autism spectrum disorder (ASD) and myotonic dystrophy type 1 (DM1), a rare neuromuscular disease.